from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0216/-

LFCtreatmentdescriptionclass of inhibitor

0.448

Amikacinug/mL Amikacintranslation

0.483

Cap5-10ug/mL Capreomycintranslation

1.853

Rox10-50 ug/mL Roxithromycintranslation

1.374

SM2-5 ug/mL Streptomycintranslation

2.180

Tet5-10 ug/mL Tetracyclinetranslation

0.632

Rif0.2-5ug/mL Rifampicintranscription

0.562

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.020

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.228

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.184

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.024

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.112

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.655

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.022

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.585

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.100

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.461

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.294

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.703

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.178

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.450

KCN5-20 ug/mL Potassium cyaniderespiration

-0.323

NaN30.2-2 mM Sodium aziderespiration

0.774

Nigericin50 uM Nigericinrespiration

-0.202

TRC10-150 ug/mL Triclosanrespiration

-1.145

TRZ10-25 ug/mL Thioridazinerespiration

-0.836

Valinomycin0.5-10 uM Valinomycinrespiration

0.771

ZnSO42 mM ZnSO4respiration

-0.364

menadione6-10 ug/mL Menadionerespiration

-0.313

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.508

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.106

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.015

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.439

NRP_1Non-replicating persistence stage 1dosRassociated

0.664

Amp0.2mg/mL AmpicillincellWall

-0.169

Cephalexin20-100 ug/mL CephalexincellWall

0.590

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.034

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.391

EMB10-20 ug/mL EthambutolcellWall

-0.352

Eta12-40 ug/mL EthionamidecellWall

0.260

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.466

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.025

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.131

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.515

BZA0.12 mg/mL BenzamidearomaticAmides

0.176

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.166

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.544

H2O24 mM hydrogen peroxideDNAdamaging

0.254

Levo10 ug/mL LevofloxacinDNAdamaging

0.220

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.899

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.015

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.562

UVUV-irradiationDNAdamaging

-1.027

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.225

Antimycin12.5-50 ug/mL Antimycin A?

-0.232

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.617

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.442

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.133

PA8240.2-2 ug/mL PA-824?

-1.014

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.238

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.076

Verapamil50 uM Verapamil?

0.479

mercaptoethanol2 mM 2-Mercaptoethanol?

0.008

methoxatin10-20 ug/mL Methoxatin?